Kovelman Harry Insider Trading Activity

Average Profitability
335.91%
Insider Buys Quantity
1
Insider Buys Sum
$4,999.80
Insider Sells Quantity
5
Insider Sells Sum
$355,195.45

Insider Activity of Kovelman Harry

According to the SEC Form 4 filings, Kovelman Harry, being in a position of

  1. Chief Medical Officer at Myomo, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 65344 shares for $82,705,
    over all time since 2023-08-29, has bought 8333 shares for $5,000, and sold 147832 shares for $437,900.

Biography of Kovelman Harry

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $82,7054100

Comparison of Insiders on Amount of Buys and Sells

2026-09-11SaleMyomo, Inc.
MYO
Chief Medical Officer
15,844
0.0363%
$1.27$20,1360%
2026-08-20SaleMyomo, Inc.
MYO
Chief Medical Officer
17,500
0.0408%
$1.73$30,329-19.83%
2026-05-28SaleMyomo, Inc.
MYO
Chief Medical Officer
11,536
0.0304%
$1.02$11,734+18.35%
2026-05-27SaleMyomo, Inc.
MYO
Chief Medical Officer
20,464
0.0531%
$1.00$20,505+29%
2025-03-12SaleMyomo, Inc.
MYO
Chief Medical Officer
30,000
0.0914%
$5.50$165,018-80.11%
2024-09-05SaleMyomo, Inc.
MYO
Chief Medical Officer
6,700
0.0221%
$3.76$25,183+8.49%
2024-09-03SaleMyomo, Inc.
MYO
Chief Medical Officer
2,029
0.0069%
$4.01$8,140+5.14%
2024-05-15SaleMyomo, Inc.
MYO
Chief Medical Officer
35,426
0.1201%
$3.69$130,839+21.16%
2023-12-01SaleMyomo, Inc.
MYO
Chief Medical Officer
8,333
0.0296%
$3.12$26,016+14.41%
2023-08-29PurchaseMyomo, Inc.
MYO
Chief Medical Officer
8,333
0.0313%
$0.60$5,000+335.91%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.